Knight Therapeutics, Inc.

Knight Therapeutics, Inc.

11.92
CAD
-0.14
(-1.16%)
0.16EPS
65.28P/E
1.04BMarket Cap
Mar 25Next Earn

Knight Therapeutics, Inc. Documents

Q3 FY2026 · Earnings release

Read Knight Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this earnings release
Create a free account to start reading

Full documents are included with Professional

Q3 FY2026 documents